Speciality Medicines Peer Comparison

BSE: 544738

₹141.80

₹-7.20 (-4.83%)

As on 23-Oct-2026IST

Market cap

₹125 Cr

Revenue (TTM)

₹75 Cr

P/E Ratio

9.6

P/B Ratio

1.7

Div. Yield

0 %

Edit

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Medi-Caps
Market cap (₹ Cr)	125	6,398	188	162	31
Revenue (₹ Cr)	75	7,128	38	100	13
Net Profit (₹ Cr)	13.03	167.66	9.79	5.00	-1.78
Net Margin (%)	17.12	2.35	25.56	4.79	-8.71
RoE (%)	25.60	7.58	99.59	9.53	-1.56
Price to Earnings	9.56	51.02	15.70	32.37	--
Price-To-Book	1.75	3.69	--	3.08	0.29

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Medi-Caps
Operating Revenue	75.29	6,591.21	--	100.23	12.45
Total Income	76.11	6,610.45	--	104.35	20.66
Total Expenditure	61.60	6,325.26	--	95.56	21.85
EBITDA	13.68	265.96	--	4.67	-9.40
Depreciation	0.17	43.29	--	0.65	1.81
EBIT	13.51	222.66	--	4.02	-11.21
Interest	1.32	54.39	--	1.66	0.02
Other Income	0.83	19.24	--	4.12	8.21
Exceptional Items	--	-8.18	--	-0.01	--
Profit before Tax	13.02	179.34	--	6.47	-3.02
Provision for Tax	-0.01	33.50	--	1.47	0.01
Profit after Tax	13.03	145.84	--	5.00	-3.04

Liabilities (₹ Cr)

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Medi-Caps
Shareholder's Funds	71.19	1,688.61	--	52.48	111.61
Minority Interest	--	63.94	--	-0.08	--
Non-Current Liabilities	5.15	206.12	--	4.66	1.14
Current Liabilities	18.88	1,587.57	--	42.23	2.71
Total Liabilities	95.22	3,600.22	--	99.64	115.46

Assets (₹ Cr)

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Medi-Caps
Non-Current Assets	6.26	1,037.80	--	23.77	68.44
Current Assets	88.97	2,503.13	--	75.53	47.02
Total Assets	95.22	3,600.22	--	99.64	115.46
Total Debt*	6.64	566.68	--	36.71	0.00
Net Current Assets	70.09	915.56	--	33.30	44.31
Contingent Liabilities	--	5.51	--	0.14	--

Cashflow (₹ Cr)

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Medi-Caps
Cash From Operating Activities	-1.28	96.20	--	-8.61	-7.02
Cash Flow from Investing Activities	-2.83	-303.06	--	-13.33	7.11
Cash from Financing Activities	27.82	123.66	--	31.59	--
Net Cash Inflow / Outflow	23.70	-83.20	--	9.65	0.09

Ratios

Profitability Ratios

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Medi-Caps
ROCE (%)	25.26	10.93	--	9.12	-2.58
ROE (%)	25.60	8.57	--	9.53	-2.61
ROA (%)	19.27	4.68	--	5.04	-2.52
EBIT Margin (%)	19.27	4.33	--	8.77	-9.59
Net Margin (%)	17.12	2.21	--	4.79	-14.70
Cash Profit Margin (%)	17.54	2.87	--	5.64	-9.88

Growth Ratios

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Medi-Caps
Revenue Growth (%)	29.20	29.35	--	0.00	-51.14
EBIT Growth (%)	54.39	35.13	--	--	-229.03
Net Profit Growth (%)	81.11	35.75	--	0.00	-431.96
EPS Growth (%)	32.67	21.32	--	0.00	-431.95
Book Value Growth (%)	132.49	-2.19	--	0.00	-7.97

Valuation Ratios

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Medi-Caps
Price / Earnings	8.49	47.12	--	25.46	0.00
Price / Book Value	1.55	3.22	--	2.43	0.26
Dividend Yield (%)	0.00	0.00	--	0.00	0.00
EV/EBITDA	6.39	20.43	--	16.66	-23.82
Market Cap (₹ Cr)	110.62	5,420.61	--	127.33	28.93

Solvency Ratios

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Medi-Caps
Debt to Equity	0.09	0.34	--	0.70	0.00
Short term debt to equity ratio	0.01	0.26	--	0.48	--
Current Ratio	4.71	1.58	--	1.79	17.34
Quick Ratio	3.21	1.05	--	1.49	16.26
Interest Coverage	10.87	4.30	--	4.89	-137.05

Operating Efficiency Ratios

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Medi-Caps
Debtors to sales (%)	35.20	18.39	--	30.52	55.60
Asset Turnover	1.11	2.11	--	1.01	0.10
Receivable days	87.52	56.56	--	111.39	230.34
Inventory Days	110.76	41.57	--	45.39	90.05
Payable days	43.45	34.66	--	32.72	71.74
Cash Conversion Cycle	154.84	63.47	--	124.06	248.65